This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why Is Cabot (CBT) Up 3.9% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot's Earnings Surpass Estimates in Q2, Revenues Miss
by Zacks Equity Research
EBIT of CBT's Reinforcement Materials falls in Q2, primarily due to lower volumes as a result of lower tire demand.
Cabot (CBT) Tops Q2 Earnings Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 2.15% and 9.83%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Olin (OLN) Tops Q1 Earnings Estimates
by Zacks Equity Research
Olin (OLN) delivered earnings and revenue surprises of 140% and 1.03%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle (ALB) Stock Jumps 19.1%: Will It Continue to Soar?
by Zacks Equity Research
Albemarle (ALB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Do Options Traders Know Something About Cabot (CBT) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Cabot (CBT) stock based on the movements in the options market lately.
Why Is Cabot (CBT) Down 7.9% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot's Earnings and Revenues Lag Estimates in Q1, EPS Up Y/Y
by Zacks Equity Research
Cabot misses Q1 earnings and revenue estimates but demonstrates better results in EBIT and adjusted EPS metrics.
Cabot (CBT) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of -2.22% and 3.83%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
LyondellBasell (LYB) Q4 Earnings Match Estimates
by Zacks Equity Research
LyondellBasell (LYB) delivered earnings and revenue surprises of 0% and 1.41%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Eastman Chemical (EMN) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 18.35% and 0.53%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Compass Minerals (CMP) Q1 Earnings Expected to Decline
by Zacks Equity Research
Compass (CMP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot (CBT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Do Options Traders Know Something About Cabot (CBT) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Cabot (CBT) stock based on the movements in the options market lately.
Cabot (CBT) Up 1.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot Increases Share Repurchase Authorization by 10 Million
by Zacks Equity Research
All repurchased shares of CBT will be retired and restored to the status of authorized but unissued common stock of the company.
Cabot's Q4 Earnings and Revenues Miss Estimates, Rise Y/Y
by Zacks Equity Research
The decline in Q4 EBIT of CBT's Reinforcement Material segment is due to reduced volumes in the Americas, a less advantageous regional mix and higher costs.
Cabot (CBT) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of -1.10% and 1.53%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Steel Dynamics' Q3 Earnings and Revenues Beat Expectations
by Zacks Equity Research
Lower average realized steel prices weigh on STLD's Q3 results amid steady underlying steel demand.
Is Harmony Gold (HMY) Stock Outpacing Its Basic Materials Peers This Year?
by Zacks Equity Research
Here is how Harmony Gold (HMY) and Cabot (CBT) have performed compared to their sector so far this year.
Here's Why Cabot (CBT) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cabot Corporation (CBT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Cabot (CBT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's What Makes CF Industries Stock a Solid Choice Right Now
by Zacks Equity Research
CF presents a compelling investment case backed by favorable nitrogen demand fundamentals, rising earnings estimates and an attractive valuation.